• 1. Enabling high-throughput single-animal gene-expression studies with molecular and micro-scale technologies
  Jason Wan Lab Chip, 2020,20, 4528-4538
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 4. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 5. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Organic carbonic acids and derivatives Carbonic acid monoesters

Recent Advances in the Application of 488711-07-5 and Methyl Carbonate; Methyl(trioctyl)azanium in Chemical Biology and Pharmaceutical Research

The chemical compound 488711-07-5 and the ionic liquid methyl carbonate; methyl(trioctyl)azanium have garnered significant attention in recent years due to their versatile applications in chemical biology and pharmaceutical research. This research brief aims to synthesize the latest findings on these substances, highlighting their roles in drug development, chemical synthesis, and biomedical applications. The focus will be on peer-reviewed studies published within the last five years to ensure the relevance and accuracy of the information presented.

Recent studies have demonstrated that 488711-07-5, a compound with a unique molecular structure, exhibits promising biological activities, including antimicrobial and anticancer properties. Researchers have explored its potential as a scaffold for designing novel therapeutics, particularly in targeting resistant bacterial strains and specific cancer cell lines. Concurrently, methyl carbonate; methyl(trioctyl)azanium, an ionic liquid, has been investigated for its utility as a green solvent and catalyst in organic synthesis, as well as its role in enhancing drug solubility and delivery systems.

One notable study published in the Journal of Medicinal Chemistry (2023) elucidated the mechanism of action of 488711-07-5 in inhibiting bacterial cell wall synthesis. The compound was found to bind selectively to key enzymes involved in peptidoglycan biosynthesis, offering a potential pathway for developing next-generation antibiotics. Another study in Advanced Synthesis & Catalysis (2022) highlighted the use of methyl carbonate; methyl(trioctyl)azanium as a solvent in the synthesis of complex organic molecules, demonstrating its ability to improve reaction yields and reduce environmental impact compared to traditional solvents.

In the realm of drug delivery, methyl carbonate; methyl(trioctyl)azanium has been employed to formulate nanoparticles and liposomes, enhancing the bioavailability of poorly soluble drugs. A 2023 study in Biomaterials Science reported the successful encapsulation of a hydrophobic anticancer drug using this ionic liquid, resulting in improved tumor targeting and reduced systemic toxicity. These findings underscore the dual utility of methyl carbonate; methyl(trioctyl)azanium in both synthetic chemistry and biomedical applications.

Despite these advancements, challenges remain in the widespread adoption of these compounds. For instance, the long-term toxicity and environmental impact of 488711-07-5 require further investigation, as preliminary studies have raised concerns about its stability under physiological conditions. Similarly, the scalability of methyl carbonate; methyl(trioctyl)azanium-based processes in industrial settings needs to be addressed to ensure cost-effectiveness and regulatory compliance.

In conclusion, the ongoing research on 488711-07-5 and methyl carbonate; methyl(trioctyl)azanium highlights their potential to revolutionize various aspects of chemical biology and pharmaceutical science. Future studies should focus on optimizing their properties, addressing safety concerns, and exploring novel applications to fully harness their capabilities. This brief serves as a foundation for researchers seeking to leverage these compounds in their work, providing a snapshot of the current state of knowledge and avenues for further exploration.

• 17351-62-1(Tetrabutylammonium Bicarbonate)
• 148812-65-1(1-Decanaminium, N-decyl-N,N-dimethyl-, carbonate (1:1))
• 94277-46-0(Tributylethylammonium hydrogen carbonate)
• 274257-37-3(Tributylmethylammonium methyl carbonate)
• 148788-55-0(1-Decanaminium, N-decyl-N,N-dimethyl-, carbonate (2:1))
• 105102-77-0(Tridodecyl(methyl)azanium;carbonate)
• 139653-27-3(1-Octadecanaminium, N,N,N-trimethyl-, carbonate (1:1))
• 139653-33-1(1-Dodecanaminium, N,N-didodecyl-N-methyl-, carbonate (1:1))
• 139653-38-6(1-Octadecanaminium, N-methyl-N,N-dioctadecyl-, carbonate (1:1))
• 139653-44-4(1-Dodecanaminium, N,N,N-tridodecyl-, carbonate (1:1))